Haik Humble Eye Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Macular degeneration2 trials
• Diabetic eye disease1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials

Lead sponsor

• EyePoint Pharmaceuticals, Inc.2 trials
• 4D Molecular Therapeutics1 trial

Running trials

• Active, not recruiting

  COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

  NCT07449936· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Recruiting

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· Phase 3· 4D Molecular Therapeutics· Source

  Contact: 4DMT Patient Advocacy

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source